Clinical Trials Browser

Phase 2 × Interventional × benralizumab × Clear all

NCT04552288 2025-07-23

Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

Phase 2 Active not recruiting

51 enrolled 8 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT05966584 2024-08-29

A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer

Phase 2 Terminated

1 enrolled 5 charts

Breast Neoplasms, Exanthema